Microbix recently received a positive announcement from the European Patent Office that the “Frozen sperm/XY” patent has been revoked by its Technical Board of Appeal.
Urokinase is a natural human protein that stimulates the human body’s blood clot-dissolving processes. It is an injectible drug and is approved in Canada and the U.S. for clinical use as a thrombolytic agent for the treatment of pulmonary embolism and coronary occlusion.
Microbix holds a valuable portfolio of intellectual property in virology, large market biotherapeutic drugs, vaccine technologies, and animal reproduction technologies.
VIRUSMAX™ technology is a process for recovery of more virus from influenza virus-infected chick embryos (eggs) to enhance influenza vaccine production.
